 | • レポートコード：MRC2Q12-18094 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、末梢動脈疾患診断のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 末梢動脈疾患診断のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 末梢動脈疾患診断の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 末梢動脈疾患診断のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの末梢動脈疾患診断の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の末梢動脈疾患診断の売上および2028年までの予測に焦点を当てています。 末梢動脈疾患診断のグローバル主要企業には、Viasonix、Koven Technology、Natus Medical、Huntleigh、Hokanson、CooperSurgical、Perimed、Atys Medical、Newman Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 末梢動脈疾患診断市場は、タイプとアプリケーションによって区分されます。世界の末梢動脈疾患診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 足首上腕指数 (ABI)、超音波検査、血管造影、その他 【アプリケーション別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 末梢動脈疾患診断製品概要 - タイプ別市場（足首上腕指数 (ABI)、超音波検査、血管造影、その他） - アプリケーション別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の末梢動脈疾患診断販売量予測2017-2028 - 世界の末梢動脈疾患診断売上予測2017-2028 - 末梢動脈疾患診断の地域別販売量 - 末梢動脈疾患診断の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別末梢動脈疾患診断販売量 - 主要メーカー別末梢動脈疾患診断売上 - 主要メーカー別末梢動脈疾患診断価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（足首上腕指数 (ABI)、超音波検査、血管造影、その他） - 末梢動脈疾患診断のタイプ別販売量 - 末梢動脈疾患診断のタイプ別売上 - 末梢動脈疾患診断のタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、その他） - 末梢動脈疾患診断のアプリケーション別販売量 - 末梢動脈疾患診断のアプリケーション別売上 - 末梢動脈疾患診断のアプリケーション別価格 ・北米市場 - 北米の末梢動脈疾患診断市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患診断市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの末梢動脈疾患診断市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の末梢動脈疾患診断市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の末梢動脈疾患診断市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患診断市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの末梢動脈疾患診断市場規模（タイプ別、アプリケーション別） - 主要国別の末梢動脈疾患診断市場規模（トルコ、サウジアラビア） ・企業情報 Viasonix、Koven Technology、Natus Medical、Huntleigh、Hokanson、CooperSurgical、Perimed、Atys Medical、Newman Medical ・産業チェーン及び販売チャネル分析 - 末梢動脈疾患診断の産業チェーン分析 - 末梢動脈疾患診断の原材料 - 末梢動脈疾患診断の生産プロセス - 末梢動脈疾患診断の販売及びマーケティング - 末梢動脈疾患診断の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 末梢動脈疾患診断の産業動向 - 末梢動脈疾患診断のマーケットドライバー - 末梢動脈疾患診断の課題 - 末梢動脈疾患診断の阻害要因 ・主な調査結果 |
Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Peripheral Arterial Disease Diagnostics estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Peripheral Arterial Disease Diagnostics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Peripheral Arterial Disease Diagnostics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Peripheral Arterial Disease Diagnostics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Peripheral Arterial Disease Diagnostics include Viasonix, Koven Technology, Natus Medical, Huntleigh, Hokanson, CooperSurgical, Perimed, Atys Medical and Newman Medical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Peripheral Arterial Disease Diagnostics companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Peripheral Arterial Disease Diagnostics market. Further, it explains the major drivers and regional dynamics of the global Peripheral Arterial Disease Diagnostics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Viasonix
Koven Technology
Natus Medical
Huntleigh
Hokanson
CooperSurgical
Perimed
Atys Medical
Newman Medical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Peripheral Arterial Disease Diagnostics Segment by Type
Ankle-Brachial Index (ABI)
Ultrasonography
Angiography
Other
Peripheral Arterial Disease Diagnostics Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Peripheral Arterial Disease Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Peripheral Arterial Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Peripheral Arterial Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peripheral Arterial Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peripheral Arterial Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Peripheral Arterial Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Peripheral Arterial Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Viasonix, Koven Technology, Natus Medical, Huntleigh, Hokanson, CooperSurgical, Perimed, Atys Medical and Newman Medical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Peripheral Arterial Disease Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Arterial Disease Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peripheral Arterial Disease Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Arterial Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ankle-Brachial Index (ABI)
1.2.3 Ultrasonography
1.2.4 Angiography
1.2.5 Other
1.3 Market by Application
1.3.1 Global Peripheral Arterial Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Arterial Disease Diagnostics Market Perspective (2017-2028)
2.2 Peripheral Arterial Disease Diagnostics Growth Trends by Region
2.2.1 Peripheral Arterial Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peripheral Arterial Disease Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Peripheral Arterial Disease Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Peripheral Arterial Disease Diagnostics Market Dynamics
2.3.1 Peripheral Arterial Disease Diagnostics Industry Trends
2.3.2 Peripheral Arterial Disease Diagnostics Market Drivers
2.3.3 Peripheral Arterial Disease Diagnostics Market Challenges
2.3.4 Peripheral Arterial Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Arterial Disease Diagnostics Players by Revenue
3.1.1 Global Top Peripheral Arterial Disease Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Peripheral Arterial Disease Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Peripheral Arterial Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Arterial Disease Diagnostics Revenue
3.4 Global Peripheral Arterial Disease Diagnostics Market Concentration Ratio
3.4.1 Global Peripheral Arterial Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease Diagnostics Revenue in 2021
3.5 Peripheral Arterial Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Peripheral Arterial Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Peripheral Arterial Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Arterial Disease Diagnostics Breakdown Data by Type
4.1 Global Peripheral Arterial Disease Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Peripheral Arterial Disease Diagnostics Forecasted Market Size by Type (2023-2028)
5 Peripheral Arterial Disease Diagnostics Breakdown Data by Application
5.1 Global Peripheral Arterial Disease Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Peripheral Arterial Disease Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peripheral Arterial Disease Diagnostics Market Size (2017-2028)
6.2 North America Peripheral Arterial Disease Diagnostics Market Size by Type
6.2.1 North America Peripheral Arterial Disease Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Peripheral Arterial Disease Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Peripheral Arterial Disease Diagnostics Market Share by Type (2017-2028)
6.3 North America Peripheral Arterial Disease Diagnostics Market Size by Application
6.3.1 North America Peripheral Arterial Disease Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Peripheral Arterial Disease Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Peripheral Arterial Disease Diagnostics Market Share by Application (2017-2028)
6.4 North America Peripheral Arterial Disease Diagnostics Market Size by Country
6.4.1 North America Peripheral Arterial Disease Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Peripheral Arterial Disease Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peripheral Arterial Disease Diagnostics Market Size (2017-2028)
7.2 Europe Peripheral Arterial Disease Diagnostics Market Size by Type
7.2.1 Europe Peripheral Arterial Disease Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Peripheral Arterial Disease Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Peripheral Arterial Disease Diagnostics Market Share by Type (2017-2028)
7.3 Europe Peripheral Arterial Disease Diagnostics Market Size by Application
7.3.1 Europe Peripheral Arterial Disease Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Peripheral Arterial Disease Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Peripheral Arterial Disease Diagnostics Market Share by Application (2017-2028)
7.4 Europe Peripheral Arterial Disease Diagnostics Market Size by Country
7.4.1 Europe Peripheral Arterial Disease Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Peripheral Arterial Disease Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Peripheral Arterial Disease Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peripheral Arterial Disease Diagnostics Market Size (2017-2028)
9.2 Latin America Peripheral Arterial Disease Diagnostics Market Size by Type
9.2.1 Latin America Peripheral Arterial Disease Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Peripheral Arterial Disease Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Peripheral Arterial Disease Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Peripheral Arterial Disease Diagnostics Market Size by Application
9.3.1 Latin America Peripheral Arterial Disease Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Peripheral Arterial Disease Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Peripheral Arterial Disease Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Peripheral Arterial Disease Diagnostics Market Size by Country
9.4.1 Latin America Peripheral Arterial Disease Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Peripheral Arterial Disease Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Peripheral Arterial Disease Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Viasonix
11.1.1 Viasonix Company Details
11.1.2 Viasonix Business Overview
11.1.3 Viasonix Peripheral Arterial Disease Diagnostics Introduction
11.1.4 Viasonix Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.1.5 Viasonix Recent Developments
11.2 Koven Technology
11.2.1 Koven Technology Company Details
11.2.2 Koven Technology Business Overview
11.2.3 Koven Technology Peripheral Arterial Disease Diagnostics Introduction
11.2.4 Koven Technology Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.2.5 Koven Technology Recent Developments
11.3 Natus Medical
11.3.1 Natus Medical Company Details
11.3.2 Natus Medical Business Overview
11.3.3 Natus Medical Peripheral Arterial Disease Diagnostics Introduction
11.3.4 Natus Medical Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.3.5 Natus Medical Recent Developments
11.4 Huntleigh
11.4.1 Huntleigh Company Details
11.4.2 Huntleigh Business Overview
11.4.3 Huntleigh Peripheral Arterial Disease Diagnostics Introduction
11.4.4 Huntleigh Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.4.5 Huntleigh Recent Developments
11.5 Hokanson
11.5.1 Hokanson Company Details
11.5.2 Hokanson Business Overview
11.5.3 Hokanson Peripheral Arterial Disease Diagnostics Introduction
11.5.4 Hokanson Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.5.5 Hokanson Recent Developments
11.6 CooperSurgical
11.6.1 CooperSurgical Company Details
11.6.2 CooperSurgical Business Overview
11.6.3 CooperSurgical Peripheral Arterial Disease Diagnostics Introduction
11.6.4 CooperSurgical Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.6.5 CooperSurgical Recent Developments
11.7 Perimed
11.7.1 Perimed Company Details
11.7.2 Perimed Business Overview
11.7.3 Perimed Peripheral Arterial Disease Diagnostics Introduction
11.7.4 Perimed Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.7.5 Perimed Recent Developments
11.8 Atys Medical
11.8.1 Atys Medical Company Details
11.8.2 Atys Medical Business Overview
11.8.3 Atys Medical Peripheral Arterial Disease Diagnostics Introduction
11.8.4 Atys Medical Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.8.5 Atys Medical Recent Developments
11.9 Newman Medical
11.9.1 Newman Medical Company Details
11.9.2 Newman Medical Business Overview
11.9.3 Newman Medical Peripheral Arterial Disease Diagnostics Introduction
11.9.4 Newman Medical Revenue in Peripheral Arterial Disease Diagnostics Business (2017-2022)
11.9.5 Newman Medical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer